These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 4981700)

  • 1. [Effect of intensive plasmapheresis on the "syndrome of increased viscosity" and blood coagulation system in Waldenstrom's macroglobulinemia].
    Mokeeva RA; Zhuravlev VS
    Probl Gematol Pereliv Krovi; 1969 Mar; 14(3):8-16. PubMed ID: 4981700
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plasmapheresis and hyperviscosity syndrome].
    Corral Alonso M; Barbolla ML
    Sangre (Barc); 1984; 29(5):940-50. PubMed ID: 6441295
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperviscosity syndrome in Waldenström's macroglobulinemia.
    Krol TC; Wood WS
    Am Fam Physician; 1981 Aug; 24(2):187-9. PubMed ID: 6789661
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hyperviscosity syndrome].
    Dumas G; Merceron S; Zafrani L; Canet E; Lemiale V; Kouatchet A; Azoulay E
    Rev Med Interne; 2015 Sep; 36(9):588-95. PubMed ID: 25778852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alleviation of ocular complications of the hyperviscosity syndrome in Waldenström's macroglobulinemia using plasma exchange].
    Malecaze F; Mathis A; Gonzales C; Lloveras JJ; Goudable C; Arlet P; Bec P
    J Fr Ophtalmol; 1986; 9(5):367-71. PubMed ID: 3100607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic effects of plasmapheresis in Waldenström's disease].
    Moulinier J; Servantie X; Mesnier F
    J Med Bord; 1967 Sep; 144(9):1295-300. PubMed ID: 4988704
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic plasmapheresis in treatment of patients with Waldenström's macroglobulinemia.
    Lawson NS; Nosanchuk JS; Oberman HA; Meyers MC
    Transfusion; 1968; 8(3):174-8. PubMed ID: 4968993
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experience with plasma exchange: application of an apparatus for plasmapheresis (Haemonetics Model 30) in hyperviscosity syndrome].
    Amamiya Y; Baba M; Hisamitsu J; Ito T; Amaki T
    Rinsho Ketsueki; 1978 Oct; 19(10):1436-8. PubMed ID: 105174
    [No Abstract]   [Full Text] [Related]  

  • 9. [Waldenström's macroglobulinemia: clinical aspects, diagnosis and therapy].
    Baldus M; Brass H
    Med Klin (Munich); 1992 Aug; 87(8):434-6. PubMed ID: 1406477
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma exchange in the long-term management of Waldenström's macroglobulinemia.
    Buskard NA; Galton DA; Goldman JM; Kohner EM; Grindle CF; Newman DL; Twinn KW; Lowenthal RM
    Can Med Assoc J; 1977 Jul; 117(2):135-7. PubMed ID: 406031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of plasmapheresis on the PF-0.5 blood separator in patients with paraproteinemic hemoblastoses].
    Abdullaev OM; Postnikov AA; Prigozhina TA; Likhovetskaia ZM; Mokeeva RA
    Ter Arkh; 1987; 59(10):77-81. PubMed ID: 2448887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of plasmapheresis in Waldenström's macroglobulinemia.
    Stone MJ; Bogen SA
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):238-40. PubMed ID: 23522642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myeloma and Waldenström's macroglobulinemia].
    Palva I
    Duodecim; 1989; 105(11):1088-94. PubMed ID: 2502371
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom's macroglobulinemia.
    Menke MN; Feke GT; McMeel JW; Treon SP
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1157-60. PubMed ID: 18326744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and rheological studies in a patient with hyperviscosity syndrome due to Waldenström's macroglobulinemia.
    Somer T; Ditzel J
    Bibl Haematol; 1981; (47):242-6. PubMed ID: 6802129
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasmapheresis in patients with leukaemia, multiple myeloma and immune complex diseases.
    Mód A; Füst G; Harsányi V; Natonek K; Poros A; Szabó J; Hollán SR
    Haematologia (Budap); 1981; 14(1):49-56. PubMed ID: 6454615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmapheresis for hyperviscosity syndrome in macroglobulinemia Waldenström and multiple myeloma: influence on blood rheology and the microcirculation.
    Reinhart WH; Lutolf O; Nydegger UR; Mahler F; Straub PW
    J Lab Clin Med; 1992 Jan; 119(1):69-76. PubMed ID: 1727909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials referral resource. Multiple myeloma and Waldenström's macroglobulinemia phase III trials.
    Cheson BD; Phillips PH
    Oncology (Williston Park); 1994 Jul; 8(7):45, 48-50. PubMed ID: 7917838
    [No Abstract]   [Full Text] [Related]  

  • 19. Nursing assessment of symptoms associated with hyperviscosity syndrome.
    Trotta P; Knobf MT
    Oncol Nurs Forum; 1987; 14(1):21-5. PubMed ID: 3101042
    [No Abstract]   [Full Text] [Related]  

  • 20. [The blood coagulation system in patients with Waldenstrom's macroglobulinemia and multiple myeloma].
    Kokeva RA; Zhuravlev VS
    Probl Gematol Pereliv Krovi; 1968 Jun; 13(6):10-5. PubMed ID: 4981865
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.